WIA StandardsKOEN

WIA Biomarker Data Standard Guide

A guide to the WIA-BIO-004 standard

Contents

Chapter 1What Is a Biomarker? From Measurement to Clinical DecisionA number becomes a biomarker only when we know what was measured, how, in whom, and what decision it is meant to support. This chapter builds that vocabulary… Chapter 2The Statistics of Diagnostic Performance: From the Confusion Matrix to ROC-AUCEvery validation claim in WIA-BIO-004 is ultimately a statement about four counts. This chapter shows how those counts become sensitivity, specificity… Chapter 3The WIA-BIO-004 Data FormatsThe records that carry a biomarker result from the analyser to the validation study: the measurement envelope, reference ranges, multi-analyte definitions… Chapter 4APIs and Tools: TypeScript SDK, CLI and RESTWhat the @wia/bio-004 TypeScript SDK, the wia-bio-004 command-line tool and the specified REST registry actually do in version 1.0, how to call them correctly… Chapter 5Analytical Validation Protocol and Quality ControlBefore a biomarker can be judged against disease, the assay must be judged against itself: how the specimen was handled, how low it can see, how much it… Chapter 6Clinical Validation and Clinical CorrelationAn assay that measures an analyte precisely has passed only the first test. This chapter covers the second and third: showing that the measurement separates… Chapter 7System Integration, Security and PrivacyA biomarker result is clinical data about an identifiable person long before it becomes a row in a validation study. This chapter shows how the WIA-BIO-004… Chapter 8Conformance Testing, Certification and the Road AheadA claim that a system “implements WIA-BIO-004” is only worth something if someone else can check it. This chapter turns the standard’s requirements into a…

About this book

A number becomes a biomarker only when we know what was measured, how, in whom, and what decision it is meant to support. This chapter builds that vocabulary and shows where each part of WIA-BIO-004 fits.

A laboratory analyser that prints "CRP 12.5 mg/L" has produced a measurement. It has not yet produced clinical knowledge. To turn that number into something a physician can act on, several further facts are needed: the assay that generated it, the specimen it came from, whether the specimen was haemolysed or left on the bench too long, the interval of values seen in comparable healthy people, and, above all, the question the result is supposed to answer. Is it being used to diagnose an acute infection, to monitor an inflammatory disease under treatment, or to estimate long-term cardiovascular risk? The same analyte, measured on the same analyser, plays a different role in each case and must be judged by different evidence.